193 related articles for article (PubMed ID: 37312930)
1. Oral Delivery of Anti-Parasitic Agent-Loaded PLGA Nanoparticles: Enhanced Liver Targeting and Improved Therapeutic Effect on Hepatic Alveolar Echinococcosis.
Li J; Yang Y; Han X; Li J; Tian M; Qi W; An H; Wu C; Zhang Y; Han S; Duan L; Wang W; Zhang W
Int J Nanomedicine; 2023; 18():3069-3085. PubMed ID: 37312930
[TBL] [Abstract][Full Text] [Related]
2. Impact of Albendazole on Cytokine and Chemokine Response Profiles in
Wu J; Ma HZ; Apaer S; Anweier N; Zeng Q; Fulati X; Li T; Zhao JM; Wen H; Tuxun T
Biomed Res Int; 2021; 2021():6628814. PubMed ID: 34041299
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Küster T; Stadelmann B; Hermann C; Scholl S; Keiser J; Hemphill A
Antimicrob Agents Chemother; 2011 Feb; 55(2):713-21. PubMed ID: 21135182
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous infection model facilitates treatment assessment of secondary Alveolar echinococcosis in mice.
Küster T; Hermann C; Hemphill A; Gottstein B; Spiliotis M
PLoS Negl Trop Dis; 2013; 7(5):e2235. PubMed ID: 23717701
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.
Joekel DE; Lundström-Stadelmann B; Müllhaupt B; Hemphill A; Deplazes P
Exp Parasitol; 2018 May; 188():65-72. PubMed ID: 29625098
[TBL] [Abstract][Full Text] [Related]
6. Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode.
Rodrigues JM; Bories C; Emery I; Fessi H; Devissaguet JP; Liance M
Int J Parasitol; 1995 Dec; 25(12):1437-41. PubMed ID: 8719955
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
Wang J; Vuitton DA; Müller N; Hemphill A; Spiliotis M; Blagosklonov O; Grandgirard D; Leib SL; Shalev I; Levy G; Lu X; Lin R; Wen H; Gottstein B
PLoS Negl Trop Dis; 2015 May; 9(5):e0003755. PubMed ID: 25955764
[TBL] [Abstract][Full Text] [Related]
8. In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.
Albani CM; Pensel PE; Elissondo N; Gambino G; Elissondo MC
Vet Parasitol; 2015 Sep; 212(3-4):193-9. PubMed ID: 26190130
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
11. Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.
Hemphill A; Spicher M; Stadelmann B; Mueller J; Naguleswaran A; Gottstein B; Walker M
Parasitology; 2007 Nov; 134(Pt 12):1657-70. PubMed ID: 17631693
[TBL] [Abstract][Full Text] [Related]
12. Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.
Huang X; Grüner B; Lechner CJ; Kern P; Soboslay PT
Med Microbiol Immunol; 2014 Jun; 203(3):185-93. PubMed ID: 24509604
[TBL] [Abstract][Full Text] [Related]
13. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice.
Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC
Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481
[TBL] [Abstract][Full Text] [Related]
14. Dual Role of Hepatic Macrophages in the Establishment of the
Wang H; Zhang CS; Fang BB; Hou J; Li WD; Li ZD; Li L; Bi XJ; Li L; Abulizi A; Shao YM; Lin RY; Wen H
Front Immunol; 2020; 11():600635. PubMed ID: 33488594
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.
Spicher M; Naguleswaran A; Ortega-Mora LM; Müller J; Gottstein B; Hemphill A
Exp Parasitol; 2008 Aug; 119(4):475-482. PubMed ID: 18442817
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
17. Unusual presentation of alveolar echinococcosis as prostatic and paraprostatic cysts in a dog.
Geigy CA; Kühn K; Rütten M; Howard J; Grimm F; Rohrer Bley C
BMC Vet Res; 2013 Aug; 9():159. PubMed ID: 23938212
[TBL] [Abstract][Full Text] [Related]
18. Treatment of echinococcosis: albendazole and mebendazole--what else?
Hemphill A; Stadelmann B; Rufener R; Spiliotis M; Boubaker G; Müller J; Müller N; Gorgas D; Gottstein B
Parasite; 2014; 21():70. PubMed ID: 25526545
[TBL] [Abstract][Full Text] [Related]
19. Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.
Liu Y; Wang XQ; Ren WX; Chen YL; Yu Y; Zhang JK; Bawudong D; Gu JP; Xu XD; Zhang XN
J Biomed Mater Res B Appl Biomater; 2013 Aug; 101(6):998-1005. PubMed ID: 23529958
[TBL] [Abstract][Full Text] [Related]
20. Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.
Stadelmann B; Rufener R; Aeschbacher D; Spiliotis M; Gottstein B; Hemphill A
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004535. PubMed ID: 26967740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
